EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility

Cristina Di Carluccio, Luis Padilla-Cortés, Marta Tiemblo-Martìn, Giulia Roxana Gheorghita, Rosario Oliva, Linda Cerofolini, Alessandro Antonio Masi, Celeste Abreu, Hsin-Kai Tseng, Antonio Molinaro, Pompea Del Vecchio, Ondřej Vaněk und 4 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202415782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Cristina Di Carluccio und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, Naples, 80126, Italy. Hauptthemen laut MEDLINE: Gangliosides, Lectins, Antigens, Differentiation, Myelomonocytic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN MUR 2022, PRIN MUR PNRR 2022, European Research Council (ERC) under the European Union's Horizon 2020 ERC-STG No 851356.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gangliosides, sialylated glycosphingolipids abundant in the nervous system, play crucial roles in neurotransmission, interaction with regulatory proteins, cell–cell recognition, and signaling. Altered gangliosides expression has been correlated with pathological processes, including cancer, inflammatory disorders, and autoimmune diseases. Gangliosides are important endogenous ligands of Siglecs (Sialic acid‐binding immunoglobulin‐type lectins), I‐type lectins mostly expressed by immune cells, that specifically recognize sialylated glycans. Siglec‐7, an inhibitory immune receptor on human natural killer cells, represents a potential target for tumor immunotherapy. Notably, the expression of Siglec‐7 ligands is high in various cancers, such as pancreatic cancer and melanoma and lead to tumor immune evasion. Siglec‐7 binds the disialylated ganglioside GD3, a tumor‐associated antigen overexpressed on cancer cells to suppress immune responses. Using a combination of structural biology techniques, including Nuclear Magnetic Resonance (NMR), biophysical, and computational methods, the binding of Siglec‐7 to GD3 and Gb3 derivatives is investigated, revealing the importance of ligand conformation in modulating binding energetics and affinity. The greater flexibility of Gb3 derivatives appears to negatively impact binding entropy, leading to lower affinity compared to GD3. A thorough understanding of these interactions could contribute to elucidating molecular mechanisms of cancer immune evasion and facilitate the development of ganglioside‐based diagnostic and therapeutic strategies for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GangliosidesLectinsAntigens, Differentiation, MyelomonocyticHumansLigandsProtein BindingMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

NMRgangliosidessiglec‐7structural biology

Substanzen

GangliosidesSIGLEC7 protein, humanLigandsLectinsAntigens, Differentiation, Myelomonocytic

Autor:innen und Institutionen

  • Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, Naples, 80126, Italy.
  • CEINGE-Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, Napoli, 80145, Italy.
  • Magnetic Resonance Centre (CERM), CIRMMP and Department of Chemistry "Ugo Schiff", University of Florence, Via Luigi Sacconi 6, Sesto Fiorentino, 50019, Italy.
  • Giotto Biotech s.r.l., Sesto Fiorentino, 50019, Italy.
  • Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, Prague, 12800, Czech Republic.
  • Department of Chemistry, National Tsing Hua University, Hsinchu, 300044, Taiwan.

ORCID-Profile: Alba Silipo

Förderung

  • PRIN MUR 2022
  • PRIN MUR PNRR 2022
  • European Research Council (ERC) under the European Union's Horizon 2020 ERC-STG No 851356
  • NextGenerationEU, ITACA.SB, Project n° IR0000009), MUR 3264/2021 PNRR M4/C2/L3.1.1
  • Ministry of Education, Universities and Research (Italy)
  • PNRR, Missione 4 - Componente 2 - NextGenerationEU - Partenariato Esteso INF-ACT - One Health Basic and Translational Research Actions Addressing Unmet Needs o…
  • H2020-MSCA-ITN
  • Accademia Nazionale dei Lincei

Zitieren

APA

Di Carluccio, C., Padilla-Cortés, L., Tiemblo-Martìn, M., Gheorghita, G. R., Oliva, R., Cerofolini, L., Masi, A. A., Abreu, C., Tseng, H. K., Molinaro, A., Del Vecchio, P., Vaněk, O., Lin, C. C., Marchetti, R., Fragai, M., & Silipo, A. (2025). Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility. Advanced Science. https://doi.org/10.1002/advs.202415782

Vancouver

Di Carluccio C, Padilla-Cortés L, Tiemblo-Martìn M, Gheorghita GR, Oliva R, Cerofolini L, et al. Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility. Advanced Science. 2025. doi:10.1002/advs.202415782

BibTeX
@article{DiCarluccio2025,
  author = {Di Carluccio, Cristina and Padilla-Cortés, Luis and Tiemblo-Martìn, Marta and Gheorghita, Giulia Roxana and Oliva, Rosario and Cerofolini, Linda and Masi, Alessandro Antonio and Abreu, Celeste and Tseng, Hsin-Kai and Molinaro, Antonio and Del Vecchio, Pompea and Vaněk, Ondřej and Lin, Chun-Cheng and Marchetti, Roberta and Fragai, Marco and Silipo, Alba},
  title = {Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202415782}
}
Kostenlos starten →